Coronary Artery Disease
A team-based approach to patients in cardiogenic shock
Jacob A. Doll MD,
E. Magnus Ohman MD,
Manesh R. Patel MD,
Carmelo A. Milano MD,
Joseph G. Rogers MD,
David H. Wohns MD, Navin K. Kapur MD, Sunil V. Rao MD,
Corresponding Author
Jacob A. Doll MD
Duke University Medical Center, Durham, North Carolina
the Duke Clinical Research Institute, Durham, North Carolina
Correspondence to: Jacob Doll, md; 2301 Erwin Road, DUMC 3845, Durham, NC 27710, USA. E-mail: [email protected]Search for more papers by this authorE. Magnus Ohman MD
Duke University Medical Center, Durham, North Carolina
the Duke Clinical Research Institute, Durham, North Carolina
Search for more papers by this authorManesh R. Patel MD
Duke University Medical Center, Durham, North Carolina
the Duke Clinical Research Institute, Durham, North Carolina
Search for more papers by this authorCarmelo A. Milano MD
Duke University Medical Center, Durham, North Carolina
Search for more papers by this authorJoseph G. Rogers MD
Duke University Medical Center, Durham, North Carolina
Search for more papers by this authorSunil V. Rao MD
Duke University Medical Center, Durham, North Carolina
the Duke Clinical Research Institute, Durham, North Carolina
Search for more papers by this authorJacob A. Doll MD,
E. Magnus Ohman MD,
Manesh R. Patel MD,
Carmelo A. Milano MD,
Joseph G. Rogers MD,
David H. Wohns MD, Navin K. Kapur MD, Sunil V. Rao MD,
Corresponding Author
Jacob A. Doll MD
Duke University Medical Center, Durham, North Carolina
the Duke Clinical Research Institute, Durham, North Carolina
Correspondence to: Jacob Doll, md; 2301 Erwin Road, DUMC 3845, Durham, NC 27710, USA. E-mail: [email protected]Search for more papers by this authorE. Magnus Ohman MD
Duke University Medical Center, Durham, North Carolina
the Duke Clinical Research Institute, Durham, North Carolina
Search for more papers by this authorManesh R. Patel MD
Duke University Medical Center, Durham, North Carolina
the Duke Clinical Research Institute, Durham, North Carolina
Search for more papers by this authorCarmelo A. Milano MD
Duke University Medical Center, Durham, North Carolina
Search for more papers by this authorJoseph G. Rogers MD
Duke University Medical Center, Durham, North Carolina
Search for more papers by this authorSunil V. Rao MD
Duke University Medical Center, Durham, North Carolina
the Duke Clinical Research Institute, Durham, North Carolina
Search for more papers by this authorAbstract
Cardiogenic shock is a common clinical condition with high in-hospital mortality. Early application of appropriate interventions for cardiogenic shock—including medical therapies, revascularization, temporary hemodynamic support devices, and durable mechanical circulatory support—may improve outcomes. The number and complexity of therapies for cardiogenic shock are increasing, making time-dependent decision-making more challenging. A multidisciplinary cardiogenic shock team is recommended to guide the rapid and efficient use of these available treatments. © 2015 Wiley Periodicals, Inc.
REFERENCES
- 1Kunadian V, Qiu W, Ludman P, Redwood S, Curzen N, Stables R, et al. Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: An analysis from the BCIS database (British Cardiovascular Intervention Society). JACC Cardiovasc Interven 2014; 7: 1374–1385.
- 2Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999; 341: 625–634.
- 3O'Gara PT, Kushner FG, Ascheim DD, Casey DE,J, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: 529–555.
- 4Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569–2619.
- 5Werdan K, Russ M, Buerke M, Delle-Karth G, Geppert A, Schondube FA, et al. Cardiogenic shock due to myocardial infarction: Diagnosis, monitoring and treatment: A German–Austrian S3 Guideline. Deutsches Arzteblatt International 2012; 109: 343–351.
- 6Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, et al. Cardiogenic shock complicating acute myocardial infarction–etiologies, management and outcome: A report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36: 1063–1070.
- 7Harjola VP, Lassus J, Sionis A, Kober L, Tarvasmaki T, Spinar J, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Failure 2015; 17: 501–509.
- 8Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005; 294: 448–454.
- 9Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc 2014; 3: e000590.
- 10Singh M, White J, Hasdai D, Hodgson PK, Berger PB, Topol EJ, et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: Insights from the GUSTO-I trial. J Am Coll Cardiol 2007; 50: 1752–1758.
- 11Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295: 2511–2515.
- 12Katz JN, Stebbins AL, Alexander JH, Reynolds HR, Pieper KS, Ruzyllo W, et al. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J 2009; 158: 680–687.
- 13Van Herck JL, Claeys MJ, De Paep R, Van Herck PL, Vrints CJ, Jorens PG. Management of cardiogenic shock complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 2015; 4: 278–297.
- 14De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362: 779–789.
- 15O'Gara PT, Kushner FG, Ascheim DD, Casey DE,J, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61: e78–e140.
- 16Unverzagt S, Wachsmuth L, Hirsch K, Thiele H, Buerke M, Haerting J, et al. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev 2014; 1: Cd009669.
- 17Van Herck JL, Claeys MJ, De Paep R, Van Herck PL, Vrints CJ, Jorens PG. Management of cardiogenic shock complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 2015.
- 18Kern MJ, Aguirre FV, Tatineni S, Penick D, Serota H, Donohue T, et al. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 1993; 21: 359–368.
- 19Mueller H, Ayres SM, Conklin EF, Giannelli S,J, Mazzara JT, Grace WT, et al. The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest 1971; 50: 1885–1900.
- 20Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584–1588.
- 21Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; 26: 1276–1283.
- 22Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol 2015; 65: e7–e26.
- 23Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-term mechanical circulatory support: Incidence, outcomes, and cost analysis. J Am Coll Cardiol 2014; 64: 1407–1415.
- 24Khera R, Cram P, Lu X, Vyas A, Gerke A, Rosenthal GE, et al. Trends in the use of percutaneous ventricular assist devices: Analysis of national inpatient sample data, 2007 through 2012. JAMA Int Med 2015; 175: 941–950.
- 25Williams DO, Korr KS, Gewirtz H, Most AS. The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation 1982; 66: 593–597.
- 26Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan JJ, Koch KT, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? Eur Heart J 2009; 30: 459–468.
- 27Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287–1296.
- 28Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomised, open-label trial. Lancet 2013; 382: 1638–1645.
- 29Lauten A, Engstrom AE, Jung C, Empen K, Erne P, Cook S, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: Results of the Impella-EUROSHOCK-registry. Circ Heart Fail 2013; 6: 23–30.
- 30Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001; 104: 2917–2922.
- 31Ouweneel DM, Henriques JP. Percutaneous cardiac support devices for cardiogenic shock: Current indications and recommendations. Heart (British Cardiac Society). 2012; 98: 1246–1254.
- 32Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152: 469 e1–e8.
- 33Sidebotham D, Allen SJ, McGeorge A, Ibbott N, Willcox T. Venovenous extracorporeal membrane oxygenation in adults: Practical aspects of circuits, cannulae, and procedures. J Cardiothorac Vasc Anesth 2012; 26: 893–909.
- 34Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: A meta-analysis of 1,866 adult patients. Ann Thorac Surg 2014; 97: 610–616.
- 35Soleimani B, Pae WE. Management of left ventricular distension during peripheral extracorporeal membrane oxygenation for cardiogenic shock. Perfusion 2012; 27: 326–331.
- 36Gass A, Palaniswamy C, Aronow WS, Kolte D, Khera S, Ahmad H, et al. Peripheral venoarterial extracorporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise. Cardiology 2014; 129: 137–143.
- 37Borisenko O, Wylie G, Payne J, Bjessmo S, Smith J, Yonan N, et al. Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: A systematic literature review and meta-analysis of observational studies. ASAIO J (Am Soc Artif Int Organs 1992) 2014; 60: 487–497.
- 38Takayama H, Soni L, Kalesan B, Truby LK, Ota T, Cedola S, et al. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail 2014; 7: 799–806.
- 39Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011; 30: 402–407.
- 40Morrison LJ, Neumar RW, Zimmerman JL, Link MS, Newby LK, McMullan PW,J, et al. Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: A consensus statement from the American Heart Association. Circulation 2013; 127: 1538–1563.
- 41Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C. Rapid response teams: A systematic review and meta-analysis. Arch Intern Med 2010; 170: 18–26.
- 42Celso B, Tepas J, Langland-Orban B, Pracht E, Papa L, Lottenberg L, et al. A systematic review and meta-analysis comparing outcome of severely injured patients treated in trauma centers following the establishment of trauma systems. J Trauma 2006; 60: 371–378.
- 43Ghosh R, Pepe P. The critical care cascade: A systems approach. Curr Opin Crit Care. 2009; 15: 279–283.
- 44Takayama H, Truby L, Koekort M, Uriel N, Colombo P, Mancini DM, et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 2013; 32: 106–111.
- 45Berg DD, Sukul D, O'Brien M, Scirica BM, Sobieszczyk PS, Olenchock BA, et al. Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2015;
- 46Jaroszewski DE, Kleisli T, Staley L, Pierce C, Scott R, Steidley DE, et al. A traveling team concept to expedite the transfer and management of unstable patients in cardiopulmonary shock. J Heart Lung Transplant 2011; 30: 618–623.
- 47Haft JW, Pagani FD, Romano MA, Leventhal CL, Dyke DB, Matthews JC. Short- and long-term survival of patients transferred to a tertiary care center on temporary extracorporeal circulatory support. Ann Thorac Surg 2009; 88: 711–717.
- 48Morris RJ, Pochettino A, O'Hara M, Gardner TJ, Acker MA. Emergent mechanical support in the community: Improvement with early transplant center referral. J Heart Lung Transplant 2005; 24: 764–768.
- 49Vazquez R, Gheorghe C, Grigoriyan A, Palvinskaya T, Amoateng-Adjepong Y, Manthous CA. Enhanced end-of-life care associated with deploying a rapid response team: A pilot study. J Hosp Med 2009; 4: 449–452.
